
First Trust NYSE Arca Biotechnology Index Fund
FBT
Updated: 22/09/2026, 10:28:23
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.
No summaries found.
- Share price
- $269.73
- Market cap
- $1.68B
- Exchange
- AMEX
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 23/06/2006
- Beta
- 0.76
- Last dividend
- $0.00
- Day range
- $269.36 – $271.21
- 52-week range
- $173.98 – $274.99
- 1-day performance
- 0.59%
- 1-year performance
- 55.04%
- Current drawdown (1Y)
- -1.91%
- CIK
- 0001329377
- CUSIP
- 33733E203
- ISIN
- US33733E2037
- Created
- 07/12/2025, 03:54:54
- Last update
- 22/09/2026, 10:28:23
Track First Trust NYSE Arca Biotechnology Index Fund with an AI analyst
See which prediction-market events move FBT, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Zacks Investment Research • STOCK • 07/05/2026, 09:21:02
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Zacks Investment Research • STOCK • 30/04/2026, 09:21:08
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Zacks Investment Research • STOCK • 03/03/2026, 08:22:17